Titre:
  • Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Auteur:Partridge, Ann H; Niman, Samuel M; Ruggeri, Monica; Peccatori, Fedro Alessandro; Azim, Hatem A; Colleoni, Marco Angelo; Saura, Cristina; Shimizu, Chikako; Sætersdal, Anna Barbro; Kroep, Judith R; Mailliez, Audrey; Warner, Ellen; Borges, Virginia F; Amant, Frédéric; Gombos, Andrea; Kataoka, Akemi; Rousset-Jablonski, Christine; Borstnar, Simona; Takei, Junko; Lee, Jeong E; Walshe, Janice M; Ruíz-Borrego, Manuel; Moore, Halle C F; Saunders, Christobel; Bjelic-Radisic, Vesna; Susnjar, Snezana; Cardoso, Fatima; Smith, Karen L; Ferreiro, Teresa; Ribi, Karin; Ruddy, Kathryn; Kammler, Roswitha; El-Abed, Sarra; Viale, Giuseppe; Piccart-Gebhart, Martine; Korde, Larissa A; Goldhirsch, Aron; Gelber, Richard D; Pagani, Olivia; International Breast Cancer Study Group, ; POSITIVE Trial Collaborators,
Informations sur la publication:The New England journal of medicine, 388, 18, page (1645-1656)
Statut de publication:Publié, 2023-05
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast Cancer
Complications of Pregnancy
Hematology/Oncology
Hematology/Oncology General
Obstetrics/Gynecology
Obstetrics/Gynecology General
MeSH keywords:Adult
Female
Humans
Pregnancy
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant
Combined Modality Therapy
Disease-Free Survival
Neoplasm Recurrence, Local -- epidemiology -- prevention & control -- drug therapy
Prospective Studies
Withholding Treatment
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0028-4793
info:doi/10.1056/NEJMoa2212856
info:scp/85160235705
info:pmid/37133584